
Future Planet Capital
Description
Future Planet Capital is a London-based, global impact-led venture capital firm dedicated to investing in technology and life science companies that emerge from the world's leading research centers. The firm distinguishes itself by focusing on solutions to pressing global challenges, leveraging deep scientific and technological innovation. Their investment strategy is rooted in identifying and nurturing groundbreaking ventures with the potential for significant societal and environmental impact.
Their investment thesis is structured around five core thematic areas: Climate Change, Health, Education, Sustainable Growth, and Security. Future Planet Capital actively seeks out university spin-outs and research-backed enterprises, providing the necessary capital and strategic support to transition academic breakthroughs into commercial successes. This approach highlights their commitment to fostering innovation at the intersection of science, technology, and global well-being.
Future Planet Capital commands substantial financial capacity, with total capital under management exceeding $400 million as of late 2023. This considerable fund size enables them to make meaningful investments across their target sectors. Typically, their initial cheque sizes range from £1 million to £5 million, demonstrating their focus on early to growth-stage companies. The firm also provides follow-on capital to support the continued development and scaling of their portfolio companies, reinforcing their long-term commitment to their ventures.
Investor Profile
Future Planet Capital has backed more than 377 startups, with 3 new investments in the last 12 months alone. The firm has led 10 rounds, about 3% of its total and boasts 19 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Seed, Undisclosed, Convertible Note rounds (top funding stages).
- Majority of deals are located in United Kingdom, United States, Canada.
- Strong thematic focus on Biotechnology, Health Care, Software.
- Typical check size: $1.3M – $6.4M.
Stage Focus
- Seed (24%)
- Undisclosed (23%)
- Convertible Note (16%)
- Series A (16%)
- Series Unknown (12%)
- Series B (4%)
- Grant (1%)
- Pre Seed (1%)
- Equity Crowdfunding (1%)
- Series C (1%)
Country Focus
- United Kingdom (93%)
- United States (6%)
- Canada (1%)
- Singapore (1%)
Industry Focus
- Biotechnology
- Health Care
- Software
- Information Technology
- Manufacturing
- Medical
- Therapeutics
- Medical Device
- Life Science
- Pharmaceutical
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.